Feb-24 – Beauty for Ashes: Finding the Good in the Suffering

Feb-24 – Survey Finds Only 11 Percent of People Living with Chronic Health Conditions Have Been Contacted by their Doctor about the COVID-19 Vaccine

Feb-24 – Managing Ankylosing Spondylitis During the COVID-19 Pandemic

Feb-24 – Enbrel: Side Effects, Cost, How to Use, and More

Feb-24 – How Medical Marijuana Has Reduced My AS Pain

Feb-23 – Art Therapy - Canadian Spondylitis Association

Feb-23 – Watch: Racial Disparities in Health Care: How Spondyloarthritis Affects Black People Differently ...

Feb-23 – 1 in 3 Patients With Autoimmune Diseases Uncertain About COVID-19 Vaccine

Feb-22 – Anti-inflammatory Diet Could Help Reduce Low Back Pain

Feb-22 – IL-17A Inhibitors Appear Effective in Treating AS, But Safety Needs Further Study

Feb-22 – Celltrion secures EU approval for its adalimumab biosimilar

Feb-22 – Moderate, high rheumatic disease activity linked to higher risk for COVID-related death

Feb-18 – SAA Facebook Live: COVID-19 Vaccines & Spondyloarthritis Update

Feb-18 – Yuflyma, Biosimilar of Humira, Approved for Use in Europe

Feb-18 – The connection between ankylosing spondylitis and eye health

Feb-18 – You ask, we answer: Will there ever be a cure for AS?

Feb-18 – Ankylosing spondylitis and the heart: What is the link?

Feb-18 – What My AxSpA Diet Looks Like

Feb-18 – Eurordis Survey: Healthcare Experience Worse for Rare Disease Patients

Feb-17 – Tough Mornings and Morning Stiffness with Axial Spondyloarthritis - AxialSpondyloarthritis.net

Feb-17 – Managing Walking Complications with Spinal Stenosis

Feb-17 – A Chat With Luke Magda About AS and the Carnivore Diet

Feb-16 – Sandoz Launches Adalimumab Biosimilar in Canada

Feb-15 – Celltrion’s Humira biosimilar gains European sales approval

Feb-15 – FDA Gives Thumb’s Up for Phase 2 Trial of Izokibep in AS Patients